HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.

AbstractBACKGROUND:
Insulin receptor substrate 4 (IRS-4) is an adaptor protein for which new evidence suggests plays a role in tumour promotion.
METHODS:
We described nuclear IRS-4 in RKO colon cancer cell lines in biopsies of patients with colorectal cancer (CRC) (n = 20) and in matched adjacent normal colorectal (MANC) tissue (n = 20).
RESULTS:
Treatment with physiological doses of IGF-1 promoted nuclear influx of IRS-4 from cellular cytosol in RKO cells. When exogenous IRS-4 was overexpressed in RKO cells, there was an increase in cyclin D1, cyclin E, E2F1, pRB Ser 809/811 and pRB Ser 705 levels compared with the empty vector-transfected cells. Some of these changes returned to control values after wortmannin treatment. Subcellular fractionation showed an overexpression of IRS-4 in the cytoplasm, membrane, and nuclei of tumour samples, whereas the levels of the protein were barely detectable in the three compartments of normal samples. Immunohistochemical studies showed positive nuclear IRS-4 staining in over 74% of the tumour cells. IRS-4 was strongly overexpressed in tumoural tissues from CRC patients compared to MANC tissues. The up-regulation of IRS-4 in CRC samples correlated significantly with the increase of several G1 checkpoint proteins including cyclin D1 (r = 0.6662), Rb (r = 0.7779), pRb Serine 809/811 (r = 0.6864), pRb serine 705 (r = 0.6261) and E2F1 (r = 0.8702).
CONCLUSIONS:
Taken together, our findings suggest that IRS-4 promotes retinoblastoma-cyclin-dependent kinase activation and it may serve as a pharmacological target since its expression is very low in normal tissue, including colonic epithelium.
AuthorsPatricia Sanmartín-Salinas, María Del Val Toledo Lobo, Fernando Noguerales-Fraguas, Miguel Toro Londoño, Antonio Jiménez-Ruiz, Luis Gonzalez Guijarro
JournalJournal of gastroenterology (J Gastroenterol) Vol. 53 Issue 8 Pg. 932-944 (Aug 2018) ISSN: 1435-5922 [Electronic] Japan
PMID29353348 (Publication Type: Journal Article)
Chemical References
  • E2F1 Transcription Factor
  • E2F1 protein, human
  • Insulin Receptor Substrate Proteins
  • Proliferating Cell Nuclear Antigen
  • Retinoblastoma Protein
  • Cyclin D1
  • Insulin-Like Growth Factor I
Topics
  • Adenocarcinoma (metabolism)
  • Adenoma (metabolism)
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (metabolism)
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Cell Nucleus (metabolism)
  • Cell Proliferation (genetics)
  • Colon (metabolism)
  • Colorectal Neoplasms (metabolism, pathology)
  • Cyclin D1 (metabolism)
  • Cytoplasm (metabolism)
  • E2F1 Transcription Factor (metabolism)
  • Female
  • Humans
  • Insulin Receptor Substrate Proteins (genetics, metabolism)
  • Insulin-Like Growth Factor I (pharmacology)
  • Liver Neoplasms (metabolism)
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Protein Transport (drug effects)
  • Rectum (metabolism)
  • Retinoblastoma Protein (metabolism)
  • Signal Transduction
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: